Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06370039
PHASE2
Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
Sponsor: Invirsa, Inc.
View on ClinicalTrials.gov
Summary
Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during 4-week repeat dosing in subjects with moderate to severe dry eye disease.
Official title: Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Adult Subjects With Moderate to Severe Dry Eye Disease
Key Details
Gender
All
Age Range
18 Years - 74 Years
Study Type
INTERVENTIONAL
Enrollment
109
Start Date
2024-03-27
Completion Date
2024-07-03
Last Updated
2026-09-18
Healthy Volunteers
No
Conditions
Interventions
DRUG
INV-102
INV-102 Ophthalmic Solution
DRUG
Vehicle
Vehicle Ophthalmic Solution
Locations (1)
iuvo BioScience
Rush, New York, United States